Legal & General Group Plc Sells 267,463 Shares of Amrize Ltd $AMRZ

Key Points

• Legal & General Group Plc cut its Amrize stake by 9.1% in the fourth quarter, selling 267,463 shares and leaving it with 2,680,769 shares worth about $146.95 million.
• Insider buying has been active, with CTO Roald Brouwer and insider Mario Gross both purchasing shares in May; insiders bought a total of 131,554 shares worth about $7.15 million over the last quarter.
• Amrize missed earnings expectations in its latest quarter, reporting EPS of -$0.16 versus a -$0.14 estimate, though revenue rose 4.7% year over year to $2.18 billion.

Legal & General Group Plc lowered its position in Amrize Ltd (NYSE:AMRZ - Free Report) by 9.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,680,769 shares of the company's stock after selling 267,463 shares during the period. Legal & General Group Plc owned 0.48% of Amrize worth $146,952,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the company. Swedbank AB bought a new position in shares of Amrize in the fourth quarter valued at approximately $2,270,000. Catalyst Funds Management Pty Ltd bought a new position in shares of Amrize in the fourth quarter valued at approximately $1,082,000. Coldstream Capital Management Inc. bought a new position in shares of Amrize in the fourth quarter valued at approximately $271,000. Jefferies Financial Group Inc. bought a new position in shares of Amrize in the fourth quarter valued at approximately $424,000. Finally, Banque Cantonale Vaudoise raised its stake in shares of Amrize by 29.2% in the fourth quarter. Banque Cantonale Vaudoise now owns 805,469 shares of the company's stock valued at $44,160,000 after acquiring an additional 181,975 shares during the last quarter.

Insider Buying and Selling at Amrize

In other Amrize news, CTO Roald Brouwer bought 1,500 shares of the stock in a transaction on Thursday, May 21st. The stock was purchased at an average price of $49.84 per share, with a total value of $74,760.00. Following the acquisition, the chief technology officer owned 19,757 shares of the company's stock, valued at approximately $984,688.88. The trade was a 8.22% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Mario Gross bought 1,200 shares of the stock in a transaction on Wednesday, May 20th. The shares were acquired at an average cost of $48.63 per share, with a total value of $58,356.00. Following the acquisition, the insider directly owned 34,747 shares in the company, valued at approximately $1,689,746.61. This trade represents a 3.58% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought a total of 131,554 shares of company stock worth $7,152,069 over the last quarter. 0.54% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on AMRZ shares. Berenberg Bank set a $70.00 price objective on shares of Amrize in a research report on Thursday, February 19th. Vertical Research upgraded shares of Amrize from a "hold" rating to a "buy" rating and set a $70.00 price objective for the company in a research report on Friday, May 1st. Wells Fargo & Company dropped their price objective on shares of Amrize from $66.00 to $65.00 and set an "overweight" rating for the company in a research report on Wednesday, April 15th. Royal Bank Of Canada dropped their price objective on shares of Amrize from $61.00 to $60.00 and set a "sector perform" rating for the company in a research report on Friday, May 1st. Finally, Stephens restated an "overweight" rating and issued a $65.00 price objective on shares of Amrize in a research report on Monday, May 18th. One equities research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $64.86.

Amrize Stock Performance

AMRZ stock opened at $52.98 on Friday. The company has a 50 day moving average price of $54.44 and a 200 day moving average price of $55.16. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94. The stock has a market capitalization of $29.30 billion and a PE ratio of 25.35.

Amrize (NYSE:AMRZ - Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported ($0.16) EPS for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.02). Amrize had a return on equity of 9.84% and a net margin of 9.70%.The business had revenue of $2.18 billion for the quarter. Amrize's revenue for the quarter was up 4.7% on a year-over-year basis. Analysts forecast that Amrize Ltd will post 2.76 EPS for the current year.

Amrize Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were issued a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize's payout ratio is currently 21.05%.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.